Greally S, Kumar M, Schlaffner C, van der Heijden H, Lawton E, Biswas D
Mol Neurodegener. 2024; 19(1):98.
PMID: 39696638
PMC: 11657859.
DOI: 10.1186/s13024-024-00782-0.
Honda Pazili T
Case Rep Neurol Med. 2024; 2024:8353492.
PMID: 39040486
PMC: 11262880.
DOI: 10.1155/2024/8353492.
Bravo C, Krukowski K, Barker S, Wang C, Li Y, Fan L
Mol Neurodegener. 2024; 19(1):51.
PMID: 38915105
PMC: 11197196.
DOI: 10.1186/s13024-024-00733-9.
Abskharon R, Pan H, Sawaya M, Seidler P, Olivares E, Chen Y
Proc Natl Acad Sci U S A. 2023; 120(41):e2300258120.
PMID: 37801475
PMC: 10576031.
DOI: 10.1073/pnas.2300258120.
Bajracharya R, Brici D, Bodea L, Janowicz P, Gotz J, Nisbet R
Acta Neuropathol Commun. 2021; 9(1):42.
PMID: 33712083
PMC: 7953551.
DOI: 10.1186/s40478-021-01147-0.
Similarities and Differences in the Pattern of Tau Hyperphosphorylation in Physiological and Pathological Conditions: Impacts on the Elaboration of Therapies to Prevent Tau Pathology.
Duquette A, Pernegre C, Carpentier A, Leclerc N
Front Neurol. 2021; 11:607680.
PMID: 33488502
PMC: 7817657.
DOI: 10.3389/fneur.2020.607680.
Alzheimer's disease brain-derived extracellular vesicles spread tau pathology in interneurons.
Ruan Z, Pathak D, Kalavai S, Yoshii-Kitahara A, Muraoka S, Bhatt N
Brain. 2020; 144(1):288-309.
PMID: 33246331
PMC: 7880668.
DOI: 10.1093/brain/awaa376.
A combinatorial native MS and LC-MS/MS approach reveals high intrinsic phosphorylation of human Tau but minimal levels of other key modifications.
Drepper F, Biernat J, Kaniyappan S, Meyer H, Mandelkow E, Warscheid B
J Biol Chem. 2020; 295(52):18213-18225.
PMID: 33106314
PMC: 7939451.
DOI: 10.1074/jbc.RA120.015882.
Constant Levels of Tau Phosphorylation in the Brain of htau Mice.
Neddens J, Daurer M, Loeffler T, Alzola Aldamizetxebarria S, Flunkert S, Hutter-Paier B
Front Mol Neurosci. 2020; 13:136.
PMID: 32982685
PMC: 7485327.
DOI: 10.3389/fnmol.2020.00136.
Understanding the Pathophysiological Actions of Tau Oligomers: A Critical Review of Current Electrophysiological Approaches.
Hill E, Wall M, Moffat K, Karikari T
Front Mol Neurosci. 2020; 13:155.
PMID: 32973448
PMC: 7468384.
DOI: 10.3389/fnmol.2020.00155.
Humanized tau antibodies promote tau uptake by human microglia without any increase of inflammation.
Zilkova M, Nolle A, Kovacech B, Kontsekova E, Weisova P, Filipcik P
Acta Neuropathol Commun. 2020; 8(1):74.
PMID: 32471486
PMC: 7257136.
DOI: 10.1186/s40478-020-00948-z.
Tau-Reactive Endogenous Antibodies: Origin, Functionality, and Implications for the Pathophysiology of Alzheimer's Disease.
Hromadkova L, Ovsepian S
J Immunol Res. 2019; 2019:7406810.
PMID: 31687413
PMC: 6811779.
DOI: 10.1155/2019/7406810.
Neuroprotective Approach of Anti-Cancer Microtubule Stabilizers Against Tauopathy Associated Dementia: Current Status of Clinical and Preclinical Findings.
Duggal P, Mehan S
J Alzheimers Dis Rep. 2019; 3(1):179-218.
PMID: 31435618
PMC: 6700530.
DOI: 10.3233/ADR-190125.
Emerging Developments in Targeting Proteotoxicity in Neurodegenerative Diseases.
McAlary L, Plotkin S, Cashman N
CNS Drugs. 2019; 33(9):883-904.
PMID: 31414322
PMC: 6776490.
DOI: 10.1007/s40263-019-00657-9.
[Anti-tau therapies-what can be expected?].
Fliessbach K, McCormick C, Kaulen B, Schneider A
Nervenarzt. 2019; 90(9):891-897.
PMID: 31332452
DOI: 10.1007/s00115-019-0758-7.
